by Annie De Groot | Oct 22, 2020 | Featured, News
PROVIDENCE, RI, October 22, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) and CUBRC, Inc. (“CUBRC”) announced today that they have been awarded a two-year, $1.1 million contract from the Office of Generic Drugs (OGD) in the Center of Drug Evaluation and Research...
by Annie De Groot | Oct 2, 2020 | Thinking Out Loud -Blog
Generic PANDAmonium I have been hanging out with an old dog – eight year old Jack, during the COVID lockdown. If you are a dog during COVID-19, long walks, lots of snuggles on the couch during Zoom meetings, what’s not to like? Hence the theme of my latest...
by Annie De Groot | Sep 23, 2020 | Events, Webinars
Catch the replay We’re sorry, but this live event has passed. You may watch the replay here. The video is hosted by Dropbox, in which case you will need to either be logged in to an account, or downlow the video in order to view the full recording. Should you...
by Annie De Groot | Sep 23, 2020 | Events, Featured
EpiVax continues to “meet” with global clients despite pandemic restrictions through virtual meetings and conferences such as TIDES: Oligonucleotide and Peptide Therapeutics Virtual! In addition to participating in a Live Panel Discussion on FDA Draft...
by Annie De Groot | Sep 21, 2020 | Events, Webinars
Thank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email...